Precursor T-Cell acute lymphoblastic leukemia/lymphoma with rare presentation in the urinary bladder
- PMID: 22184539
- PMCID: PMC3238488
- DOI: 10.4081/hr.2011.e18
Precursor T-Cell acute lymphoblastic leukemia/lymphoma with rare presentation in the urinary bladder
Abstract
We present the 16th reported case of Acute Lymphoblastic Leukemia (ALL) with involvement in the bladder. Our patient was a 22 year-old man with T-cell ALL with a mediastinal mass. He received hyperfractionated cyclophos-phamide, vincristine, doxorubicin, dexamethasone (HyperCVAD) with mediastinal radiation. Prior to starting maintenance, he relapsed in the bladder and marrow. He received a nelarabine-based induction regimen and achieved remission. This was followed by an unrelated 11/12 HLA-matched myeloablative allogeneic stem cell transplant. He is in complete remission for the past 409 days.
Keywords: allogeneic stem cell transplantation.; bladder involvement; precursor t-cell acute lymphoblastic leukemia/lymphoma.
Conflict of interest statement
Conflict of interest: the authors report no conflicts of interest.
Figures
Similar articles
-
Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.Haematologica. 2015 May;100(5):653-61. doi: 10.3324/haematol.2014.118588. Epub 2015 Feb 14. Haematologica. 2015. PMID: 25682595 Free PMC article. Clinical Trial.
-
Complete remission with romidepsin in a patient with T-cell acute lymphoblastic leukemia refractory to induction hyper-CVAD.Hematol Oncol. 2018 Feb;36(1):340-343. doi: 10.1002/hon.2421. Epub 2017 May 30. Hematol Oncol. 2018. PMID: 28560733 Free PMC article.
-
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.J Clin Oncol. 2004 Jul 15;22(14):2816-25. doi: 10.1200/JCO.2004.07.130. J Clin Oncol. 2004. PMID: 15254049
-
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience.Ter Arkh. 2018 Aug 17;90(7):38-50. doi: 10.26442/terarkh201890738-50. Ter Arkh. 2018. PMID: 30701921 Review.
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
References
-
- Jabbour EJ, Faderl S, Kantarjian HM. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2005;80:1517–27. - PubMed
-
- Jones B, Freeman AI, Shuster JJ, et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol. 1991;19:269–75. - PubMed
-
- Stryckmans P, Debusscher L. Chemotherapy of adult acute lymphoblastic leukemia. Baillieres Clin Haematol. 1991;4:115–30. - PubMed
-
- Thomas DA, O'Brien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004;104:1624–30. - PubMed
-
- Song KW, Barnett MJ, Gascoyne RD, et al. Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes. Ann Oncol. 2007;18:535–40. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous